Class Action

Robitussin Non-Drowsy Claims

Class Action

Robitussin Non-Drowsy Claims


Case Name (Date)

Papalia et al. v GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
22-cv-2630, S.D.N.Y.
(March 2022)


Product/Service

Robitussin


Allegations

Falsely marketing products as non-drowsy when an ingredient (dextromethorphan, or DXM) in them causes drowsiness


Status

Pending



Class-Action Tracker

Abreva

Class Action

Abreva

Allegations: Misleadingly marketing Abreva cold sore treatments

Benefiber Prebiotic Supplement

Class Action

Benefiber Prebiotic Supplement

In August 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare for allegedly misleadingly advertising Benefiber Prebiotic Supplement as “100% Natural” when, according to plaintiffs, the company uses a…

Boostrix

Class Action

Boostrix

In May 2020, a class-action lawsuit was filed against GlaxoSmithKline for allegedly falsely advertising the medication Boostrix in what has been referred to as “The Big Bad Cough” advertising campaign.…

Total Hydration ChapStick

Class Action

Total Hydration ChapStick

December 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. September 2016: A class-action…

Chapstick Lip Balms with Sunscreen

Class Action

Chapstick Lip Balms with Sunscreen

In May 2019, a class-action lawsuit was filed against Wyeth Consumer Healthcare for allegedly misleadingly marketing – on the front of the package — that its Chapstick lip balm-sunscreen products…


The Latest

Filters